Amgen’s Otezla notches win in genital psoriasis
Synopsis- Otezla trumped placebo in adults with moderate to severe genital psoriasis and moderate to severe plaque psoriasis, top-line results from Amgen’s…
Synopsis- Otezla trumped placebo in adults with moderate to severe genital psoriasis and moderate to severe plaque psoriasis, top-line results from Amgen’s…
Australian biotech giant CSL is negotiating with Vifor Pharma Group to acquire the Swiss company for A$10 billion ($7.1 billion), says the…
Synopsis : SPARC enters agreement with Biomodifying to gain rights on antibody to treat cancer Sun Pharma Advanced Research Company (SPARC) gained…
SYNOPSIS: New 510(k) clearance expands the use of MammoScreen from 2D to 3D mammography, opening up the entire breast cancer screening market.…
KEYPOINTS: QIAGEN (QGEN) and DiaSorin said that the U.S. Food and Drug Administration has approved the LIAISON QuantiFERON-TB Gold Plus assay for…
HIGHLIGHTS: Spain’s top research institution struck a licensing deal that paves the way for its COVID-19 antibody test to be produced more…
Synopsis: The FDA granted orphan drug designation to GC012F, a novel chimeric antigen receptor T-cell therapy for the treatment of relapsed or…
Amneal Pharmaceuticals, Inc. on Tuesday announced it has acquired Puniska Healthcare Pvt. Ltd. for a total value of $93 million, or approximately…
Key Point – First patient reported outcome data on Tenapanor from OPTIMIZE trial demonstrates improved overall patient experience and benefit of one…
KEYWORDS: Dunad Therapeutics, a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies, announces that it has entered a strategic…